The Approved Cancer Drug List: The Good, Bad & Ugly

Date: 2022-11-08

Time: 20:00

Do you know that not all cancer drugs are claimable under Medishield life with effect from 1st Sep 2022? This has been the talk of the town in the recent months! If you have not heard about it, or are curious about how it affects the finances of you and your loved ones, do join us in this upcoming webinar. In this session, we will share more on the below:

 

–             Background on shield plans & rising medical inflation

–             The Reason for the Approved Cancer Drug list & its Limitations

–             Future of Shield plans

–             Managing Your Healthcare Premiums

–             Alternative Solutions for a Peace of Mind

Speakers:

The Approved Cancer Drug List: The Good, Bad & Ugly
Damien Goh
Wealth Advisory Director Representing Financial Alliance Pte Ltd
Damien Goh is a MDRT Court-of-The-Table Member with 15 years in the Finance Industry. He is an established Wealth Coach to Practitioners and his clients alike with a firm belief that Financial Education is the foundation to a Fuss-Free Life. With a personal interest in helping people get out from being part of the “Sandwiched Generation,” Damien’s outreach has seen him as a regular speaker at Community and Corporate Seminars on Personal Finance for both Families and Working Professionals.
The Approved Cancer Drug List: The Good, Bad & Ugly
Winnie Chan
Wealth Advisory Director Representing Financial Alliance Pte Ltd
Winnie Chan, a Certified Financial Planner, has more than 10years’ experience in financial advisory services. She believes that with the right knowledge, everyone can achieve their financial dreams. As part of her community outreach program, she has conducted several successful talks at companies which benefitted the staff. In recognition for her financial competency, she has been awarded with MDRT (COT) Membership.